For example, hepatic IGF-I-deficient mice with reduced circulating IGF-I levels showed a reduced incidence of colon and breast tumorigenesis [24, 25]; however, this effect was not observed in models of prostate cancer or osteosarcoma [26, 27]. The gene discussed is IGF1; the disease is prostate cancer.